Welcome to our dedicated page for ARHH news (Ticker: ARHH), a resource for investors and traders seeking the latest updates and insights on ARHH stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect ARHH's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of ARHH's position in the market.
Assure Holdings Corp. (OTCQB: ARHH) has expanded its intraoperative neuromonitoring services in Arizona, adding new surgeons to its platform, which will facilitate approximately 1,000 orthopedic spine cases annually. This growth is aimed at capturing business development opportunities in the Phoenix area. Additionally, the company will grant 1,620,000 incentive stock options to its team at an exercise price of US$1.06 per share, intended to retain talent and align employee interests with company performance. Forward-looking statements indicate a goal of increasing case volume by at least 40% in 2021.
Assure Holdings (OTC PINK:ARHH) will present at the virtual Fall Investor Summit on November 16-18, 2020. This event features 75 companies and over 300 investors, aiming to connect small and microcap businesses with potential investors. In addition to its core business in intraoperative neurophysiological monitoring (IONM), Assure is launching a telehealth service for IONM. The company has performed over 6,400 procedures, generating $18 million in revenue during 2019, and is recognized for high-quality patient care.
Assure Holdings Corp. reported record cash collections in 2020, surpassing the total for 2019 within just nine months. The company achieved its highest monthly procedures to date in September, performing over 900 cases and indicating a strong recovery from COVID-19 disruptions. Cash collections exceeded US$10.1 million in the first three quarters compared to US$8.0 million for the entirety of 2019. The company aims to increase its commercial insurance revenue from in-network agreements from 20% to 30% by year-end, with long-term goals of 50% by the end of 2021.
Assure Holdings Corp. (OTCQB: ARHH) announced its participation in two investor conferences this October 2020. CEO John Farlinger will present at the Lytham Partners Virtual Investor Growth Conference on October 8 at 12:00 p.m. ET and at the MicroCap Rodeo Best Ideas Bowl on October 13 at the same time. Both events will include one-on-one meetings with institutional investors. Assure specializes in intraoperative neuromonitoring services, enhancing patient care during surgeries. For more information, visit Assure Neuromonitoring.
